Vergoeding 2018-2022 voor ATC-subgroep R06AX : Overige antihistaminica voor systemisch gebruik
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| R06AX13 Loratadine (Hooikoortstablet loratadine htp ®) | 286.290 | 287.310 | 299.130 | 286.130 | 283.010 |
| R06AX17 Ketotifen (Zaditen ®) | 148.170 | 149.080 | 144.980 | 154.910 | 177.060 |
| R06AX18 Acrivastine (Semprex ®) | 170.100 | 175.580 | 203.760 | 201.550 | 182.080 |
| R06AX22 Ebastine (Kestine ®) | 269.950 | 279.280 | 274.560 | 250.480 | 254.560 |
| R06AX25 Mizolastine (Mizollen ®) | 518.220 | 550.440 | 578.530 | 572.320 | 563.070 |
| R06AX26 Fexofenadine (Telfast ®) | 1.622.100 | 1.889.800 | 1.814.800 | 1.950.000 | 2.617.300 |
| R06AX27 Desloratadine (Aerius ®) | 4.742.900 | 5.022.800 | 3.916.500 | 4.444.200 | 4.713.100 |
| R06AX28 Rupatadine (Rupafin ®) | 365.670 | 512.780 | 635.440 | 715.490 | 925.290 |
| Totaal | 8.123.400 | 8.867.070 | 7.867.700 | 8.575.080 | 9.715.470 |